Generated with Avocode.Line 2Line 3
RapidAI Announces $75 Million Growth Investment
MUSC Revolutionizing Stroke and Aneurysm Care with RapidAI
Miranda Shaw

Miranda Shaw

Miranda Shaw, PhD, MBA, is the Senior Product Manager for RapidAI's comprehensive pulmonary embolism solution. She has directed commercialization of innovative and revolutionary healthcare products in cardiology, peripheral vascular, orthopedics, and digital health.

Recent Posts

Miranda Shaw | October 22, 2021

Transforming PE care: The power of patient data and analytics

In addition to facilitating communication between specialists in pulmonary embolism (PE) care teams, AI solutions such as RapidAI can assist PE care...
Miranda Shaw | July 15, 2021

Transforming diagnosis and treatment of pulmonary embolism

Given the range of symptoms that present when a patient has a sudden blockage of one or more pulmonary arteries, quickly diagnosing and treating...